Allison N. Schorzman

955 total citations
24 papers, 772 citations indexed

About

Allison N. Schorzman is a scholar working on Oncology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Allison N. Schorzman has authored 24 papers receiving a total of 772 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Biomedical Engineering and 8 papers in Biomaterials. Recurrent topics in Allison N. Schorzman's work include Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (6 papers) and Lung Cancer Research Studies (3 papers). Allison N. Schorzman is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Nanoplatforms for cancer theranostics (6 papers) and Lung Cancer Research Studies (3 papers). Allison N. Schorzman collaborates with scholars based in United States, Italy and Germany. Allison N. Schorzman's co-authors include William C. Zamboni, Andrew T. Lucas, Joseph M. DeSimone, J. Christopher Luft, Kevin S. Chu, Charles J. Bowerman, Joseph Piscitelli, Lauren Price, Allison M. Deal and Ryan Bash and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Allison N. Schorzman

23 papers receiving 758 citations

Peers

Countries citing papers authored by Allison N. Schorzman

Since Specialization

Citations

This map shows the geographic impact of Allison N. Schorzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison N. Schorzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison N. Schorzman more than expected).

Fields of papers citing papers by Allison N. Schorzman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison N. Schorzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison N. Schorzman. The network helps show where Allison N. Schorzman may publish in the future.

Co-authorship network of co-authors of Allison N. Schorzman

This figure shows the co-authorship network connecting the top 25 collaborators of Allison N. Schorzman. A scholar is included among the top collaborators of Allison N. Schorzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison N. Schorzman. Allison N. Schorzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A mucoadhesive biodissolvable thin film for localized and rapid delivery of lidocaine for the treatment of vestibulodynia 2021 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), Panita Maturavongsadit, Rima Janusziewicz, (unknown), (unknown), Brian Button, Allison N. Schorzman, William C. Zamboni, (unknown), Stephanie A. Montgomery, Erin T. Carey, S. Rahima Benhabbour	12
2	Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective 2021 ·Antibodies ·Andrew T. Lucas, Amber S. Moody, Allison N. Schorzman, William C. Zamboni	25
3	2′-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model 2021 ·SHILAP Revista de lepidopterología ·(unknown), Allison N. Schorzman, William C. Zamboni, Lei Peng, Russell J. Mumper, Ping Ma, S. Rahima Benhabbour	0
4	Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat Glioblastoma 2020 ·ACS Applied Materials & Interfaces ·Elizabeth G. Graham-Gurysh, Kathryn M. Moore, Allison N. Schorzman, Taek Lee, William C. Zamboni, Shawn Hingtgen, Eric M. Bachelder, Kristy M. Ainslie	43
5	MerTK inhibition decreases immune suppressive glioblastoma-associated macrophages and neoangiogenesis in glioblastoma microenvironment 2020 ·Neuro-Oncology Advances ·Yuting Su, Madison Butler, Meili Zhang, Wei Zhang, Hua Song, Lee Hwang, Andy D. Tran, Ryan Bash, Allison N. Schorzman, Ying Pang, Guangyang Yu, William C. Zamboni, Xiaodong Wang, Stephen V. Frye, Christopher R. Miller, Dragan Maric, Masaki Terabe, Mark R. Gilbert, H. Shelton Earp, Jing Wu	24
6	Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer 2019 ·International Journal of Gynecological Cancer ·Sarah E. Taylor, (unknown), Heidi Donovan, Allison N. Schorzman, (unknown), William C. Zamboni, Robert P. Edwards, Kristin K. Zorn	5
7	Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients 2019 ·Antibodies ·Andrew T. Lucas, Ryan Robinson, Allison N. Schorzman, Joseph Piscitelli, (unknown), William C. Zamboni	26
8	Impact of formulation on the iontophoretic delivery of the FOLFIRINOX regimen for the treatment of pancreatic cancer 2018 ·Cancer Chemotherapy and Pharmacology ·James D. Byrne, Mohammad Raheel Jajja, Adrian T. O’Neill, Allison N. Schorzman, Amanda W. Keeler, J. Christopher Luft, William C. Zamboni, Joseph M. DeSimone, Jen Jen Yeh	9
9	Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents 2018 ·Methods in molecular biology ·Allison N. Schorzman, Andrew T. Lucas, (unknown), William C. Zamboni	9
10	Factors Affecting the Pharmacology of Antibody–Drug Conjugates 2018 ·Antibodies ·Andrew T. Lucas, Lauren Price, Allison N. Schorzman, (unknown), Joseph Piscitelli, (unknown), William C. Zamboni	89
11	Complex Effects of Tumor Microenvironment on the Tumor Disposition of carrier-mediated Agents 2017 ·Nanomedicine ·Andrew T. Lucas, Lauren Price, Allison N. Schorzman, William C. Zamboni	12
12	Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer 2016 ·Nano Letters ·Charles J. Bowerman, James D. Byrne, Kevin S. Chu, Allison N. Schorzman, Amanda W. Keeler, (unknown), Jillian L. Perry, J. Christopher Luft, David B. Darr, Allison M. Deal, Mary E. Napier, William C. Zamboni, Norman E. Sharpless, Charles M. Perou, Joseph M. DeSimone	92
13	Iontophoretic device delivery for the localized treatment of pancreatic ductal adenocarcinoma 2016 ·Proceedings of the National Academy of Sciences ·James D. Byrne, Mohammad Raheel Jajja, Allison N. Schorzman, Amanda W. Keeler, J. Christopher Luft, William C. Zamboni, Joseph M. DeSimone, Jen Jen Yeh	19
14	Evaluation of the efficiency of tumor and tissue delivery of carrier-mediated agents (CMA) and small molecule (SM) agents in mice using a novel pharmacokinetic (PK) metric: relative distribution index over time (RDI-OT) 2014 ·Journal of Nanoparticle Research ·(unknown), Sumit Rawal, (unknown), (unknown), Allison N. Schorzman, Allison M. Deal, Feng Lan, Ping Ma, Russell J. Mumper, Joseph M. DeSimone, William C. Zamboni	13
15	Particle Replication in Nonwetting Templates Nanoparticles with Tumor Selective Alkyl Silyl Ether Docetaxel Prodrug Reduces Toxicity 2014 ·Nano Letters ·Kevin S. Chu, (unknown), Allison N. Schorzman, (unknown), J. Christopher Luft, Charles J. Bowerman, Mary E. Napier, Zishan A. Haroon, William C. Zamboni, Joseph M. DeSimone	37
16	2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model 2014 ·International Journal of Nanomedicine ·Russell J. Mumper, Lei Peng, Allison N. Schorzman, S. Rahima Benhabbour, Ping Ma, (unknown), William C. Zamboni	8
17	Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy 2013 ·Biomaterials ·Kevin S. Chu, Allison N. Schorzman, (unknown), Charles J. Bowerman, Lei Peng, J. Christopher Luft, (unknown), Andrew Z. Wang, William C. Zamboni, Joseph M. DeSimone	100
18	Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer 2013 ·PLoS ONE ·Carey K. Anders, Bárbara Adamo, Olga Karginova, Allison M. Deal, Sumit Rawal, David B. Darr, Allison N. Schorzman, Charlene Santos, Ryan Bash, Tal Kafri, Lisa A. Carey, C. Ryan Miller, Charles M. Perou, Norman E. Sharpless, William C. Zamboni	74
19	Identification of Maillard reaction products on peanut allergens that influence binding to the receptor for advanced glycation end products 2013 ·Allergy ·Geoffrey A. Mueller, Soheila J. Maleki, Kenneth L. Johnson, Barry K. Hurlburt, Heng Cheng, Sanbao Ruan, Jacqueline B. Nesbit, Anna Pomés, Laura Edwards, Allison N. Schorzman, Leesa J. Deterding, Hae‐Sim Park, K. B. Tomer, Robert E. London, Jason G. Williams	60
20	Modeling of the DNA-binding site of yeast Pms1 by mass spectrometry 2011 ·DNA repair ·Allison N. Schorzman, L. Perera, (unknown), Lars C. Pedersen, Lee G. Pedersen, Thomas A. Kunkel, Kenneth B. Tomer	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact